NikoleV Posted February 29 Share Posted February 29 "Our goal is to use T cell engineering to stop DTPCs from growing and ultimately prevent the development of drug resistance in patients who are living with EGFR-positive lung cancer. This would improve not only the duration of their lives, but also the quality." Read our interview with Dr. Alexandre Reuben as he discusses using T cells to tackle drug resistance in EGFR+ lung cancer. https://www.lungevity.org/blogs/using-t-cells-to-tackle-drug-resistance-in-egfr-lung-cancer Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.